SchwerdtfegerLMontiniFLanserTEkwudoMZurawskiJTauhidSet alGut microbiota and metabolites are linked to disease progression in multiple sclerosis
[DOI] [PubMed] [Google Scholar] 130.Zhou X., Wong V.W., Zheng M
It has been approved by regulatory authorities for the treatment of type 2 diabetes and has demonstrated effectiveness in lowering the risk of cardiovascular death in individuals with existing cardiovascular disease and type 2 diabetes
BPC-157 Side Effects in Oral Research Use BPC-157 is generally regarded as having a favorable safety profile, particularly in preclinical studies involving animals
It's a deliberate decision rooted in the compound's purpose and desired effect
Clinical trial data and post-marketing surveillance have documented gastrointestinal complaints in a substantial proportion of patients, with nausea being the most frequent (reported in 1540% of patients depending on the specific agent and dose), followed by vomiting, diarrhoea, constipation, and dyspepsia